$19.87
-0.30% (Daily)
Market Cap
$1.06B
Revenue
$358.00M
Rank by MCap
#1081
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. John Walter Hanna Jr.
Headquarters
Brisbane, CA
Employees
644
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients...
Loading chart…